These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
440 related articles for article (PubMed ID: 18199572)
1. Impact of anti-tachycardia pacing on atrial fibrillation burden when added on top of preventive pacing algorithms: results of the prevention or termination (POT) trial. Mont L; Ruiz-Granell R; Martínez JG; Carmona JR; Fidalgo M; Cobo E; Riera M; Navarro X; Europace; 2008 Jan; 10(1):28-34. PubMed ID: 18199572 [TBL] [Abstract][Full Text] [Related]
2. Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AFTherapy study. Camm AJ; Sulke N; Edvardsson N; Ritter P; Albers BA; Ruiter JH; Lewalter T; Capucci PA; Hoffmann E; Europace; 2007 Dec; 9(12):1110-8. PubMed ID: 18042619 [TBL] [Abstract][Full Text] [Related]
3. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study. Kantharia BK; Freedman RA; Hoekenga D; Tomassoni G; Worley S; Sorrentino R; Steinhaus D; Wolkowicz JM; Syed ZA; Europace; 2007 Nov; 9(11):1024-30. PubMed ID: 17913697 [TBL] [Abstract][Full Text] [Related]
4. Impact of atrial antitachycardia pacing and atrial pace prevention therapies on atrial fibrillation burden over long-term follow-up. Gillis AM; Morck M; Exner DV; Sheldon RS; Duff HJ; Mitchell BL; Wyse GD Europace; 2009 Aug; 11(8):1041-7. PubMed ID: 19460849 [TBL] [Abstract][Full Text] [Related]
5. Individualized selection of pacing algorithms for the prevention of recurrent atrial fibrillation: Results from the VIP registry. Lewalter T; Yang A; Pfeiffer D; Ruiter J; Schnitzler G; Markert T; Asklund M; Przibille O; Welz A; Esmailzadeh B; Linhart M; Lüderitz B Pacing Clin Electrophysiol; 2006 Feb; 29(2):124-34. PubMed ID: 16492296 [TBL] [Abstract][Full Text] [Related]
6. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study. Sulke N; Silberbauer J; Boodhoo L; Freemantle N; Kamalvand K; O'Nunain S; Hildick-Smith D; Lloyd GW; Patel NR; Paul V Europace; 2007 Sep; 9(9):790-7. PubMed ID: 17562750 [TBL] [Abstract][Full Text] [Related]
7. Dynamic and dual-site atrial pacing in the prevention of atrial fibrillation: The STimolazione Atrial DInamica Multisito (STADIM) Study. De Simone A; Senatore G; Donnici G; Turco P; Romano E; Gazzola C; Stabile G Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S71-4. PubMed ID: 17302722 [TBL] [Abstract][Full Text] [Related]
8. Right atrial preventive and antitachycardia pacing for prevention of paroxysmal atrial fibrillation in patients without bradycardia: a randomized study. Hemels ME; Ruiter JH; Molhoek GP; Veeger NJ; Wiesfeld AC; Ranchor AV; van Trigt M; Pilmeyer A; Van Gelder IC; ; Europace; 2008 Mar; 10(3):306-13. PubMed ID: 18245199 [TBL] [Abstract][Full Text] [Related]
9. Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device. Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Boriani G; Piccione G; DiGiovanni N; Colletti A; Puntrello C; Butera G; Vasco C; Vaccaro I; Scardace G; Grammatico A; Europace; 2006 Jul; 8(7):465-73. PubMed ID: 16798758 [TBL] [Abstract][Full Text] [Related]
10. No evidence of automatic atrial overdrive pacing efficacy on reduction of paroxysmal atrial fibrillation. de Voogt W; van Hemel N; de Vusser P; Mairesse GH; van Mechelen R; Koistinen J; van den Bos A; Roose I; Voitk J; Yli-Mäyry S; Stockman D; El Allaf D; Tse HF; Lau CP Europace; 2007 Sep; 9(9):798-804. PubMed ID: 17670782 [TBL] [Abstract][Full Text] [Related]
11. Reduction of atrial fibrillation burden by atrial overdrive pacing: experience with an improved algorithm to reduce early recurrences of atrial fibrillation. Pürerfellner H; Urban L; de Weerd G; Ruiter J; Brandt J; Havlicek A; Hügl B; Widdershoven J; Kornet L; Kessels R Europace; 2009 Jan; 11(1):62-9. PubMed ID: 19008238 [TBL] [Abstract][Full Text] [Related]
12. Septal atrial pacing for the prevention of atrial fibrillation. Hakacova N; Velimirovic D; Margitfalvi P; Hatala R; Buckingham TA Europace; 2007 Dec; 9(12):1124-8. PubMed ID: 18024494 [TBL] [Abstract][Full Text] [Related]
13. [A preliminary study on the role of anti-atrial fibrillation pacemaker in the prevention of atrial tachyarrhythmia]. Yang JF; Tong JB; Wang ZL; Zhou T; Li M; Wu SJ Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Sep; 33(9):824-6. PubMed ID: 16266459 [TBL] [Abstract][Full Text] [Related]
14. The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study. Veasey RA; Arya A; Silberbauer J; Sharma V; Lloyd GW; Patel NR; Sulke AN Europace; 2011 Jun; 13(6):815-20. PubMed ID: 21208945 [TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial. Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G; Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135 [TBL] [Abstract][Full Text] [Related]
16. [Effect of antitachycardia pacemaker on atrial tachyarrhythmia detection, prevention and termination]. Bai R; Wang TM; Lin L; Kam R; Wee St; Wang L Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):333-7. PubMed ID: 16776927 [TBL] [Abstract][Full Text] [Related]
18. Rationale and design of a randomized clinical trial to assess the role of overdrive and triggered prevention pacing therapies in reducing atrial fibrillation: the Study of Atrial Fibrillation Reduction (SAFARI). Gold MR; Hoffmann E; Am Heart J; 2006 Aug; 152(2):231-6. PubMed ID: 16875902 [TBL] [Abstract][Full Text] [Related]
19. Brady-tachy syndrome: rapid atrial pacing efficacy in preventing atrial fibrillation recurrence assessed by reliable electrograms: the prefib pilot study. Flammang D; Loteanu V; Hamani D; Lambiez M; Flammang-Dorie G Europace; 2005 Sep; 7(5):482-9. PubMed ID: 16087114 [TBL] [Abstract][Full Text] [Related]
20. The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias. Funck RC; Boriani G; Manolis AS; Püererfellner H; Mont L; Tukkie R; Pisapia A; Israel CW; Grovale N; Grammatico A; Padeletti L; Am Heart J; 2008 Sep; 156(3):445-51. PubMed ID: 18760124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]